GNPX240621P2500
- 2.20
- 0.000.00%
Genprex Newsroom
Genprex | 10-Q: Quarterly report
Express News | HC Wainwright & Co. Reiterates Buy on Genprex, Maintains $10 Price Target
Genprex Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 316.67% HC Wainwright & Co. → $10 Reiterates Buy → Buy 04/04/2024 316.67% HC Wainwright & Co. →
Genprex's Promising Clinical Trials and Leadership Drive Buy Rating
Genprex Dosing Subjects in Trial of Combination Therapy for Small-cell Lung Cancer
Express News | Genprex Inc: Acclaim-3 Study Supported by FDA Orphan Drug and Fast Track Designations
Express News | Genprex Inc: Expects to Initiate Phase 2 Expansion Study in Second Half of 2024
Express News | Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination With Tecentriq® to Treat Small Cell Lung Cancer
Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination With Tecentriq to Treat Small Cell Lung Cancer
Expects to Initiate the Phase 2 Expansion Study in the Second Half of 2024 Acclaim-3 Study Supported by FDA Orphan Drug and Fast Track Designations AUSTIN, Texas — (May
Genprex Appoints Toscano As Chairman
Express News | Genprex Announces the Appointment of Jose a. Moreno Toscano as Chairman of the Board of Directors
Genprex Announces the Appointment of Jose A. Moreno Toscano As Chairman of the Board of Directors
Follows the Recent Appointment of Ryan Confer as Genprex President and CEO and to its Board of Directors AUSTIN, Texas — (May 13, 2024) — Genprex, Inc. ("Genprex" or the "Company")
Genprex Co-founder, CEO Passes Away
Genprex Co-Founder, CEO Rodney Varner Dies of Cancer
By Sabela Ojea Genprex said co-founder, chief executive and chairman of the board Rodney Varner has died of sudden cancer complications. The clinical-stage therapy company developing therapies for p
Genprex Names Ryan Confer as CEO, President >GNPX
Genprex Names Ryan Confer as CEO, President >GNPX
Express News | Genprex Inc - Ryan Confer Appointed Genprex President and CEO and to Its Board of Directors
Genprex: Chairman, CEO Rodney Varner Dies
Genprex: Chairman, CEO Rodney Varner Dies
Press Release: Genprex Announces the Passing of Its Co-Founder and Chief Executive Officer, Rodney Varner
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner PR Newswire AUSTIN, Texas, May 8, 2024 Ryan Confer Appointed Genprex President and CEO and to its Board of
Genprex Announces the Passing of Its Co-Founder and Chief Executive Officer, Rodney Varner
Ryan Confer Appointed Genprex President and CEO and to its Board of Directors AUSTIN, Texas — (May 8, 2024) — Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-s
Genprex to Present and Participate at Upcoming May Investor and Industry Conferences
AUSTIN, Texas — (May. 1, 2024) — Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with